Case Review Form

      * Denotes required field.


      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address




      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Oklahoma man suffered three hemorrhaging episodes caused by Plavix

Filed July 11th, 2012 Laurie

An Oklahoma man claims he suffered gastrointestinal and cerebral hemorrhaging as a result of taking the blood thinner drug, Plavix.

A lawsuit has been filed on his behalf by the national law firm of Parker Waihchman LLP, which represents numerous victims of severe bleeding episodes as a result of taking Plavix. The lawsuit was filed in late June in Supreme Court of the State of New York.

The Oklahoma man claims he took Plavix to prevent blood clots that could cause heart attack, stroke, or death, from March until November 2010. In December of that year, he suffered his second bout of gastrointestinal bleeding after already suffering one episode as well as an episode of cerebral hemorrhaging.

The lawsuit is seeking damages for “severe and permanent injuries, physical impairment and disfigurement, physical pain and suffering, mental pain and suffering, loss of enjoyment of life and past, present and future sums of money incurred from medical expenses associated with monitoring and treating his injuries,” according to a firm press release.

Additionally, the Oklahoma man claims Bristol-Myers Squibb and Sanofi-Aventis were each aware of the risks associated with Plavix, specifically its link to severe hemorrhaging episodes, but continued to market the drug as safe, generating more than $42 billion in sales since it was released in 1997.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!